Yonhap Infomax News3d ago
CJ CheilJedang Corp. is expected to post weak Q1 earnings with operating profit down 19.68% year-on-year to 267.6 billion won as its bio business struggles with China-driven oversupply, though analysts predict a second-half recovery as market conditions normalize and anti-dumping measures take effect.
#YonhapInfomax #CJCheilJedang #BioBusiness #Q1Earnings #AminoAcids #ChinaOversupply #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=115523
CJ CheilJedang Q1 Earnings Expected to Disappoint as Bio Business Hits Bottom

CJ CheilJedang Corp. is expected to post weak Q1 earnings with operating profit down 19.68% year-on-year to 267.6 billion won as its bio business struggles with China-driven oversupply, though analysts predict a second-half recovery as market conditions normalize and anti-dumping measures take effect.

Yonhap Infomax
Yonhap Infomax NewsApr 7
Dongwon Industries appoints Nam Taek-jong, former RFBio CEO, as executive director of management strategy to spearhead bio business expansion and M&A initiatives, though the company states no specific bio sector deals are currently under consideration.
#YonhapInfomax #DongwonIndustries #NamTaekjong #RFBio #BioBusiness #ManagementStrategy #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=114191
Dongwon Industries Appoints Former RFBio CEO Nam Taek-jong

Dongwon Industries appoints Nam Taek-jong, former RFBio CEO, as executive director of management strategy to spearhead bio business expansion and M&A initiatives, though the company states no specific bio sector deals are currently under consideration.

Yonhap Infomax
LaborjournalApr 3

#BioBusiness #PlötzlichWissen
Spaß an der Wissenschaft und Neugier wecken! Genau das wollten Julia Schnetzer, André Lampe und Inga Marie Ramcke mit ihrem Projekt "Plötzlich Wissen" erreichen. Unangekündigt traten sie an unkonventionellen Orten auf.
Zurzeit suchen die drei nach neuen Finanzierungsmöglichkeiten.

Bettina Dupont sprach mit Julia Schnetzer über ihre Erfahrungen:
https://www.laborjournal.de/editorials/3467.php

#Laborjournal #lifesci #WissKomm #Dugong #Alltagswissen #GuerillaScience

Yonhap Infomax NewsMar 24
CJ CheilJedang's new CEO Yoon Seok-hwan apologizes for collusion scandals and declining profits, pledging comprehensive reforms and preventive measures as the company targets recovery with global expansion strategy and operational efficiency improvements across food and bio business segments.
#YonhapInfomax #CJCheilJedang #YoonSeokhwan #OperatingProfit #BioBusiness #GlobalStrategicProducts #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=111659
CJ CheilJedang CEO Yoon Seok-hwan Apologizes for Poor Performance, Vows Preventive Measures

CJ CheilJedang's new CEO Yoon Seok-hwan apologizes for collusion scandals and declining profits, pledging comprehensive reforms and preventive measures as the company targets recovery with global expansion strategy and operational efficiency improvements across food and bio business segments.

Yonhap Infomax
LaborjournalMar 15

#Biobusiness
„Wir bringen mit unserem Ballaststoff gleichzeitig Süße, Textur und Volumen in Lebensmittel ein – genau wie Zucker“.

Das bonner Transferprojekt Sweethoven Biotech entwickelt einen Ballaststoff, der die Süße von Zucker mit den gesundheitsfördernden Eigenschaften von Präbiotika vereint. Welche Etappen die angehenden Jungunternehmer bereits gemeistert haben, lest ihr hier: https://www.laborjournal.de/editorials/3451.php

#Laborjournal #LifeSci
#Süßungsmittel #Biotech #Mikrobiologie #Innovation #Fortschritt

LaborjournalMar 2

#Biobusiness
Hoffnung für die #Verbrennungsmedizin: Das künstliche #Hauttransplantat #denovoSkin des Zürcher Start-ups #Cutiss könnte ein Wendepunkt für die #RekonstruktiveChirurgie sein.

Es ahmt die Eigenschaften menschlicher Haut realistisch nach und kann in nur vier Wochen hergestellt werden. Aktuell läuft eine Phase-3-Studie.

Mehr dazu im Artikel von Carolin Sage: https://www.laborjournal.de/editorials/3442.php

#Laborjournal #LifeSci #Hautgewebetherapie #BioTec #Medizin #Fortschritt #Innovation

Yonhap Infomax NewsFeb 19
Samsung C&T Corp. will invest up to 9.4 trillion won ($7.1 billion) over three years in energy and bio sectors, while raising its minimum dividend per share by 25% to 2,500 won, as part of a strategy to drive growth and enhance shareholder returns.
#YonhapInfomax #SamsungCT #Investment #EnergySector #BioBusiness #DividendPolicy #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=105840
Samsung C&T to Invest up to 9.4 Trillion Won Over Three Years in Energy and Bio Sectors

Samsung C&T Corp. will invest up to 9.4 trillion won ($7.1 billion) over three years in energy and bio sectors, while raising its minimum dividend per share by 25% to 2,500 won, as part of a strategy to drive growth and enhance shareholder returns.

Yonhap Infomax
Yonhap Infomax NewsFeb 9
CJ CheilJedang reported a 21.6% drop in Q4 operating profit due to weak domestic food and bio segments, but results beat market expectations as overseas food sales hit a record high.
#YonhapInfomax #CJCheilJedang #OperatingProfit #Q4Results #BioBusiness #OverseasFoodSales #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=104599
Yonhap Infomax NewsFeb 9
CJ CheilJedang is projected to report a 26% drop in Q4 operating profit, as both its food and bio divisions faced weak demand and increased competition, with analysts citing intensified processed food rivalry and a surge in Chinese bio supply as key factors.
#YonhapInfomax #CJCheilJedang #OperatingProfit #FoodBusiness #BioBusiness #Q4Earnings #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=104459
CJ CheilJedang Forecasts 26% Drop in Q4 Operating Profit – Weakness in Food and Bio Divisions

CJ CheilJedang is projected to report a 26% drop in Q4 operating profit, as both its food and bio divisions faced weak demand and increased competition, with analysts citing intensified processed food rivalry and a surge in Chinese bio supply as key factors.

Yonhap Infomax
LaborjournalFeb 2

#Biobusiness
Das Start-up #Ymolution entwickelt synthetische Nano-Antikörper mittels Sporen-Oberflächen-Display. Damit umgehen die Gründer nicht nur Schwächen herkömmlicher Hybridom- oder Phagenverfahren, sondern schaffen auch eine neue Dimension funktionaler Vielfalt sowie eine deutlich reduzierte Produktionszeit. Was das mit Alpakas zu tun hat? - Im Artikel von Tobias Ludwig: https://www.laborjournal.de/editorials/3421.php

#Laborjournal #LifeSciences #OpenScience #AntibodyEngineering #Vegan #LabLife #Greifswald